AstraZeneca advances scientific leadership in cardiovascular and renal diseases with

AstraZeneca advances scientific leadership in cardiovascular and renal diseases with over 60 abstracts collectively at ASN Kidney Week 2022 and AHA Scientific Sessions 2022 AstraZeneca US source

More in Leadership · More in Companies · More in Business